Back

COMPARE-TAVI 1: SAPIEN 3 vs. Myval transcatheter heart valves for transcatheter aortic valve implantation

31 August 2025 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: A year in review: key trials in coronary and structural interventions shaping guidelines and patient care Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ashkan Eftekhari

Aalborg University Hospital, Aalborg (Denmark)

4 More presentations in this session

Presentation thumbnail
FLAVOUR II: angiography-derived fractional flow reserve vs. intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease
Professor B. Koo (Seoul, KR)
Slides Video
Presentation thumbnail
ECLIPSE: orbital atherectomy vs. balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies
Doctor P. Genereux (Morristown, US)
Slides Video
Presentation thumbnail
DapaTAVI: dapagliflozin in patients undergoing transcatheter aortic valve implantation
Professor B. Ibanez (Madrid, ES)
Slides Video
Presentation thumbnail
A year in review: key trials in coronary and structural interventions shaping guidelines and patient care - discussion
Video

Access the full session

Session thumbnail
A year in review: key trials in coronary and structural interventions shaping guidelines and patient care
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 08:51 CET
You may be interested in
thumbnail
Congress Presentation
Coronary stents and transcatheter therapies for structural heart disease: what have we learnt in 2025?
thumbnail
Congress Session
Transcatheter aortic valve implantation
thumbnail
Congress Presentation
Safety and efficacy of the Myval transcatheter heart valve: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources